Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 20, 2014, Pages 7319-7324

  Hsieh, Chen Lin ^a   Fei, Teng ^a   Chen, Yiwen ^a,b   Li, Tiantian ^a   Gao, Yanfei ^c   Wang, Xiaodong ^a   Sun, Tong ^a   Sweeney, Christopher J ^a   Lee, Gwo Shu Mary ^a   Chen, Shaoyong ^c   Balk, Steven P ^c   Liu, Xiaole Shirley ^a,b   Brown, Myles ^a   Kantoff, Philip W ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; LOCKED NUCLEIC ACID; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; RNA; SMALL INTERFERING RNA;

ANDROGEN RESPONSE ELEMENT III; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; ENHANCER REGION; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; LNCAP CELL LINE; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA STRUCTURE; TRANSCRIPTION INITIATION;

CHROMOSOMAL LOOPING; KLK3E/AR/MED1 COMPLEX;

ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; KALLIKREINS; MALE; MEDIATOR COMPLEX SUBUNIT 1; PROMOTER REGIONS, GENETIC; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REGULATORY SEQUENCES, NUCLEIC ACID; RNA INTERFERENCE; TISSUE KALLIKREINS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84901020399     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1324151111     Document Type: Article

References (32)

1. Heinlein CA, Chang C (2004) Androgen receptor in prostate cancer. Endocr Rev 25(2): 276-308.
2. Knudsen KE, Penning TM (2010) Partners in crime: Deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol Metab 21(5):315-324.
3. Nelson PS (2012) Molecular states underlying androgen receptor activation: A framework for therapeutics targeting androgen signaling in prostate cancer. J Clin Oncol 30(6):644-646.
4. Hendriksen PJM, et al. (2006) Evolution of the androgen receptor pathway during progression of prostate cancer. Cancer Res 66(10):5012-5020.
5. Massie CE, et al. (2011) The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J 30(13):2719-2733.
6. Baek SH, et al. (2006) Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells. Proc Natl Acad Sci USA 103(9):3100-3105.
7. Yuan X, Balk SP (2009) Mechanisms mediating androgen receptor reactivation after castration. Urol Oncol 27(1):36-41.
8. De Santa F, et al. (2010) A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 8(5):e1000384.
9. Kim T-K, et al. (2010) Widespread transcription at neuronal activity-regulated enhancers. Nature 465(7295):182-187.
10. Wang D, et al. (2011) Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 474(7351):390-394.
11. Orom UA, Shiekhattar R (2013) Long noncoding RNAs usher in a new era in the biology of enhancers. Cell 154(6):1190-1193.
12. Orom UA, et al. (2010) Long noncoding RNAs with enhancer-like function in human cells. Cell 143(1):46-58.
13. Melo CA, et al. (2013) eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell 49(3):524-535.
14. Lam MT, et al. (2013) Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 498(7455):511-515.
15. Mousavi K, et al. (2013) eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol Cell 51(5):606-617.
16. Hah N, Murakami S, Nagari A, Danko CG, Kraus WL (2013) Enhancer transcripts mark active estrogen receptor binding sites. Genome Res 23(8):1210-1223.
17. Li W, et al. (2013) Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 498(7455):516-520.
18. Lai F, et al. (2013) Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 494(7438):497-501.
19. Yu J, et al. (2010) An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 17(5):443-454.
20. Lawrence MG, Lai J, Clements JA (2010) Kallikreins on steroids: Structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. Endocr Rev 31(4):407-446.
21. Wang Q, et al. (2009) Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138(2):245-256.
22. Chen Z, et al. (2011) Phospho-MED1-enhanced UBE2C locus looping drives castrationresistant prostate cancer growth. EMBO J 30(12):2405-2419.
23. Jin F, Claessens F, Fondell JD (2012) Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif. J Biol Chem 287(2):858-870.
24. Kong S, Bohl D, Li C, Tuan D (1997) Transcription of the HS2 enhancer toward a cislinked gene is independent of the orientation, position, and distance of the enhancer relative to the gene. Mol Cell Biol 17(7):3955-3965.
25. Stanbrough M, et al. (2006) Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 66(5): 2815-2825.
26. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY (2011) Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell 44(4):667-678.
27. Kim H-J, Park YI, Dong M-S (2006) Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays. Toxicol In Vitro 20(7):1159-1167.
28. Arora VK, et al. (2013) Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell 155(6):1309-1322.
29. Rinn JL, et al. (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129(7):1311-1323.
30. Prensner JR, et al. (2011) Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol 29(8):742-749.
31. Yang L, et al. (2013) lncRNA-dependent mechanisms of androgen-receptor- regulated gene activation programs. Nature 500(7464):598-602.
32. Li Q, et al. (2013) Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 152(3):633-641.